Biotherapeutics startup Hummingbird Bioscience brings its total Series B funding to $25 million

Biotherapeutics startup Hummingbird Bioscience brings its total Series B funding to $25 million

Hummingbird Bioscience, a startup focused on developing new treatments for cancer and other diseases, announced today it has added $6 million to its previously announced Series B, bringing the rounds total to $25 million.
The extension was led by SK Holdings…
Read More

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *